{
    "medicine_id": "2d8e6602efa4b34b0377943326bf4835510e6c24",
    "platform_id": "DB08910",
    "metadata": {
        "name": "Imnovid 1 mg Capsule",
        "composition": "1 mg Pomalidomide",
        "clinical_particulars": {
            "therapeutic_indications": "Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy",
            "contraindications": {
                "disease": "Most common adverse reactions 30 included fatigue and asthenia neutropenia anemia constipation nausea diarrhea dyspnea upper respiratory tract infections back pain and pyrexia",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pomalidomide is more potent than thalidomide 100 times and lenalidomide 10 times",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n1 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Interferon gamma 1b is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pegaspargase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Interferon beta 1b is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Alefacept is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Efalizumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2b is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Daclizumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Bevacizumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Phenylalanine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of adverse effects can be increased when Bortezomib is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Cladribine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Carmustine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Amsacrine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Bleomycin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Chlorambucil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Raltitrexed is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Mitomycin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of adverse effects can be increased when Vindesine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Floxuridine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Indomethacin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Tioguanine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Streptozocin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Trifluridine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Epirubicin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Lenalidomide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Altretamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Zidovudine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Cisplatin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of adverse effects can be increased when Vincristine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Pentostatin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of adverse effects can be increased when Methotrexate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Prednisone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Pemetrexed is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of adverse effects can be increased when Irinotecan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Temozolomide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Penicillamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Azacitidine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Carboplatin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Dactinomycin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Cytarabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Azathioprine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Melphalan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Fludarabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Flucytosine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Capecitabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Trilostane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Idarubicin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Estramustine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Lomustine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Eculizumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Decitabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Nelarabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Ciclesonide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Stepronin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Castanospermine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Vorinostat is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when 2 Methoxyethanol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Brequinar is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of adverse effects can be increased when Thiotepa is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Aldosterone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of adverse effects can be increased when Ixabepilone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Pirfenidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Belinostat is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of adverse effects can be increased when Trabectedin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Briakinumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Human interferon omega 1 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of adverse effects can be increased when Panobinostat is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Mepolizumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Abetimus is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Belatacept is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Bendamustine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Pralatrexate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Wortmannin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Eribulin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Belimumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ocrelizumab"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of adverse effects can be increased when Busulfan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Desoximetasone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Fluorometholone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of neutropenia can be increased when Pomalidomide is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Enoxacin"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB14025",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Clinafloxacin"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Furafylline"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Pomalidomide can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Pomalidomide may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pomalidomide may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Pomalidomide may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Pomalidomide may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of myelosuppression can be increased when Metamizole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Leflunomide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Pomalidomide may increase the immunosuppressive activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Pomalidomide may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Pamidronic acid"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Zoledronic acid"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Alendronic acid"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Ibandronate"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Clodronic acid"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Risedronic acid"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Tiludronic acid"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Incadronic acid"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Cocaine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Flupentixol"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Promethazine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Sulpiride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of adverse effects can be increased when Fenfluramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Thioridazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Moricizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when Benzphetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Granisetron is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of adverse effects can be increased when Diethylpropion is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Hexafluronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Naratriptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Zaleplon is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Desloratadine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Ramelteon is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Acetophenazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Melatonin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Clonazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Vigabatrin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Methyprylon is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Phenacemide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Doxacurium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Bupropion is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Halothane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Cyclizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Chlormezanone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Pergolide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Desflurane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Oxymorphone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Levetiracetam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dezocine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Estazolam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Dantrolene is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Mivacurium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Levodopa is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Decamethonium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Alimemazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Pancuronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Pipecuronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Vecuronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Butobarbital is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Heptabarbital is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Glutethimide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when gamma Hydroxybutyric acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when MMDA is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Bufotenine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Diamorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Midomafetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Fencamfamin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when 4 Methoxyamphetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Camazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Etorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Difenoxin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Delorazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Dextromoramide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Desomorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Carfentanil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Drotebanol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Cloxazolam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Bromazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Clotiazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Cathinone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Fludiazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Oxprenolol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Prazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Quazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Cinolazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Nitrazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Periciazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Acepromazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Alverine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Molindone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Pipotiazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Thioproperazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Thiothixene is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Rolipram is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when 7 Nitroindazole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when S Ethylisothiourea is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Domoic Acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Oxitriptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Phencyclidine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Clorgiline is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Valpromide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Phenethylamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Aniracetam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Iproniazid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Methapyrilene is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nialamide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Nomifensine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Urethane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Methaqualone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Amineptine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Flunarizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Osanetant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Cilansetron is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Bifeprunox is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Pagoclone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Renzapride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Iloperidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Ezogabine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when APD791 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Methsuximide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Pimavanserin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Brivaracetam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Naronapride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Naluzotan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when PRX 08066 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when BL 1020 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Gantacurium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Cariprazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Lumateperone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when YKP 1358 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Sertindole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Asenapine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Tolperisone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Levocetirizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Ziconotide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Amisulpride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Dotarizine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Clomethiazole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Deramciclane is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Tramiprosate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Ocinaplon is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Gaboxadol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Adipiplon is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Dextofisopam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Saredutant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Esmirtazapine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Vilazodone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Fospropofol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Triclofos is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Mebutamate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Sulthiame is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Cinitapride is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Serotonin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when DPDPE is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Amphetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Almotriptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Rizatriptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Pindolol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Penbutolol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Rasagiline is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when Metamfetamine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Lorcaserin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Lurasidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Trimipramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Ergometrine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Yohimbine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Iloprost is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Defibrotide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Beraprost is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Cangrelor is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Triflusal is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Pomalidomide can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "Pomalidomide may increase the myelosuppressive activities of Lipegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Pomalidomide can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00039",
                        "description": "The therapeutic efficacy of Palifermin can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Pentamidine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Loxoprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "Leuprolide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "Goserelin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Ibutilide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Fosinopril may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Labetalol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Phentolamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tamsulosin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lisinopril may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Nateglinide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "Gadobenic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Perindopril may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Terbutaline may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "Amantadine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Salbutamol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tolbutamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Iodixanol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Varenicline may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Arformoterol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Amrinone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Oxybenzone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Fenproporex may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Valganciclovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Sorbitol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Pegaptanib may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Migalastat may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Pentaerythritol tetranitrate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Ipilimumab may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Icatibant may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Alogliptin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Prasugrel may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Doripenem may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Nalmefene may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Droxidopa may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Saxagliptin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "Telavancin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Flupirtine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Dalfampridine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Gadofosveset trisodium may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Methyltestosterone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Ammonium chloride may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Mangafodipir may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Methylnaltrexone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Plerixafor may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tiopronin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Triethylenetetramine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Ioflupane I 123 may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Deferiprone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "N methylnicotinamide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Teduglutide may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Pomalidomide may decrease the excretion rate of Macitentan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Pomalidomide may decrease the excretion rate of Ceftolozane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Pomalidomide may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Pomalidomide may decrease the excretion rate of Idebenone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Pomalidomide may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Pomalidomide may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Pomalidomide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Pomalidomide may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Pomalidomide may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Pomalidomide may decrease the excretion rate of Dienogest which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Pomalidomide may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Pomalidomide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Pomalidomide may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Pomalidomide may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Pomalidomide may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Pomalidomide may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Pomalidomide may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Pomalidomide may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Pomalidomide may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Pomalidomide may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Pomalidomide may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Pomalidomide may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Pomalidomide may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Pomalidomide may decrease the excretion rate of Lorpiprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Pomalidomide may decrease the excretion rate of Arotinolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Pomalidomide may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Pomalidomide may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Pomalidomide may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Pomalidomide may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Pomalidomide may decrease the excretion rate of Nicorandil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Pomalidomide may decrease the excretion rate of Dextran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Pomalidomide may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Pomalidomide may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Pomalidomide may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Pomalidomide may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Pomalidomide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Pomalidomide may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Pomalidomide may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Pomalidomide may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Pomalidomide may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Pomalidomide may decrease the excretion rate of Synthetic Conjugated Estrogens A which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Pomalidomide may decrease the excretion rate of Synthetic Conjugated Estrogens B which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Pomalidomide may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Pomalidomide may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Pomalidomide may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Pomalidomide may decrease the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Pomalidomide may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Pomalidomide may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Pomalidomide may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Pomalidomide may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Pomalidomide may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Pomalidomide may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Pomalidomide may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Pomalidomide may decrease the excretion rate of Enalaprilat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Pomalidomide may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "Pomalidomide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Pomalidomide may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Pomalidomide may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Pomalidomide may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Pomalidomide may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Pomalidomide may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Pomalidomide may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Pomalidomide may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Pomalidomide may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Pomalidomide may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Pomalidomide may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Pomalidomide may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Pomalidomide may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Pomalidomide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Pomalidomide may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Pomalidomide may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Pomalidomide may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Pomalidomide may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Pomalidomide may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Pomalidomide may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Pomalidomide may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Pomalidomide may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Pomalidomide may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Pomalidomide may decrease the excretion rate of Antithrombin III human which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Pomalidomide may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Pomalidomide may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Pomalidomide may decrease the excretion rate of Delafloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Pomalidomide may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Pomalidomide may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Pomalidomide may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "Pomalidomide may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Pomalidomide may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Pomalidomide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Pomalidomide may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Pomalidomide may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Pomalidomide may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Pomalidomide may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Pomalidomide may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Pomalidomide may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Pomalidomide may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Pomalidomide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Pomalidomide may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Pomalidomide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Pomalidomide may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Pomalidomide may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Pomalidomide may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Pomalidomide may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Pomalidomide may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Pomalidomide may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Pomalidomide may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Pomalidomide may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Pomalidomide may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Pomalidomide may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Pyrithione may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Pomalidomide may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Pomalidomide may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tadalafil may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Pomalidomide may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Chloroquine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Pomalidomide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Pomalidomide may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Bepotastine may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Permethrin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Pomalidomide may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Pomalidomide may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Pomalidomide may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Pomalidomide may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Pomalidomide may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Pomalidomide may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Pomalidomide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Methyclothiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Bendroflumethiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Benzthiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Hydroflumethiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Chlorothiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Trichlormethiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Polythiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cyclopenthiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Indapamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Pomalidomide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Cicletanine may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The serum concentration of Trazodone can be decreased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Tipranavir can be decreased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Palbociclib can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Methylene blue can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Velpatasvir"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Voxilaprevir"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Sildenafil can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Conivaptan can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Amiodarone can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Saquinavir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Ticagrelor can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Lomitapide can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Istradefylline can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ripretinib"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Dabrafenib can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Bosentan"
                    },
                    {
                        "drugbank-id": "DB14240",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Echinacea"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The metabolism of Sarilumab can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The metabolism of Eslicarbazepine acetate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The metabolism of Lesinurad can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Alpelisib"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Fluprednidene can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Meprednisone can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Dexamethasone isonicotinate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Deflazacort can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Cortivazol can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Prednylidene can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Cloprednol can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Fluticasone can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Mometasone furoate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Hydrocortisone acetate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Hydrocortisone succinate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The metabolism of Barbexaclone can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The metabolism of Eslicarbazepine can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Cefradine"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Metyrapone"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Formestane"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Trametinib can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Estradiol acetate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Fluocortolone can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Clobetasol can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Vitamin E"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Flucloxacillin"
                    },
                    {
                        "drugbank-id": "DB00357",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Aminoglutethimide"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00485",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Dicloxacillin"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Ivermectin"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Clofibrate"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00769",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Hydrocortamate"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Orlistat"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Fosaprepitant"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Seratrodast"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Brigatinib"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Prednisolone acetate"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Difluocortolone can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ergotamine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Naloxone"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Elvitegravir"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11779",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Danoprevir"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The metabolism of Zimelidine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The metabolism of Milnacipran can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The metabolism of Desvenlafaxine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Seproxetine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The metabolism of Indalpine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Nicardipine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Isradipine"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Danazol"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB14019",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fosnetupitant"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The metabolism of Citalopram can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Dapoxetine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ceritinib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01369",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Quinupristin"
                    },
                    {
                        "drugbank-id": "DB01764",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dalfopristin"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Bifonazole"
                    },
                    {
                        "drugbank-id": "DB04894",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Vapreotide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lanreotide"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09099",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Somatostatin"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Piperaquine"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Paroxetine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The metabolism of Doramectin can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Elbasvir can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Resveratrol"
                    },
                    {
                        "drugbank-id": "DB11198",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Peppermint oil"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Capsaicin"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Oxybutynin can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Methylergometrine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mefloquine"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB00954",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dirithromycin"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01085",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pilocarpine"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01152",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Candicidin"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB01873",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Epothilone D"
                    },
                    {
                        "drugbank-id": "DB03010",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Patupilone"
                    },
                    {
                        "drugbank-id": "DB04070",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with 6 Deoxyerythronolide B"
                    },
                    {
                        "drugbank-id": "DB05482",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with 7 ethyl 10 hydroxycamptothecin"
                    },
                    {
                        "drugbank-id": "DB05814",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with GPI 1485"
                    },
                    {
                        "drugbank-id": "DB05903",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with KOS 1584"
                    },
                    {
                        "drugbank-id": "DB06174",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Noscapine"
                    },
                    {
                        "drugbank-id": "DB06233",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ridaforolimus"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cethromycin"
                    },
                    {
                        "drugbank-id": "DB06469",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lestaurtinib"
                    },
                    {
                        "drugbank-id": "DB06587",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mitemcinal"
                    },
                    {
                        "drugbank-id": "DB09308",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Solithromycin"
                    },
                    {
                        "drugbank-id": "DB09309",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Kitasamycin"
                    },
                    {
                        "drugbank-id": "DB11383",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Carbomycin"
                    },
                    {
                        "drugbank-id": "DB11405",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Eprinomectin"
                    },
                    {
                        "drugbank-id": "DB11442",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Oleandomycin"
                    },
                    {
                        "drugbank-id": "DB11459",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Selamectin"
                    },
                    {
                        "drugbank-id": "DB11470",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tildipirosin"
                    },
                    {
                        "drugbank-id": "DB11471",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tilmicosin"
                    },
                    {
                        "drugbank-id": "DB11475",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tylosin"
                    },
                    {
                        "drugbank-id": "DB11554",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tylvalosin"
                    },
                    {
                        "drugbank-id": "DB11752",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Bryostatin 1"
                    },
                    {
                        "drugbank-id": "DB11805",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Saracatinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12266",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Epofolate"
                    },
                    {
                        "drugbank-id": "DB12391",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Sagopilone"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB12532",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Oxetacaine"
                    },
                    {
                        "drugbank-id": "DB13287",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Miocamycin"
                    },
                    {
                        "drugbank-id": "DB13338",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Flurithromycin"
                    },
                    {
                        "drugbank-id": "DB13409",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rokitamycin"
                    },
                    {
                        "drugbank-id": "DB13456",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Midecamycin"
                    },
                    {
                        "drugbank-id": "DB13633",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mepartricin"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cobimetinib"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Nintedanib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Duvelisib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The metabolism of Gilteritinib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cephalexin"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tenofovir alafenamide"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tenofovir"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Allylestrenol"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Methysergide"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Tazemetostat can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Albendazole"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Prucalopride"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Famciclovir"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pranlukast"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Vitamin D"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydroergocornine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with 9 aminocamptothecin"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Methylprednisone"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydroergocryptine"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Elexacaftor"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pentoxifylline"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ropivacaine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Zolmitriptan"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tacrine"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Triamterene"
                    },
                    {
                        "drugbank-id": "DB00442",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Entecavir"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Flutamide"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00744",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Zileuton"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Levobupivacaine"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Praziquantel"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Hesperetin"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Oxtriphylline"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Theobromine"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Fenethylline"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with 8 azaguanine"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Xanthine"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with 9 Methylguanine"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Peldesine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Phenacetin"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Hypoxanthine"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with 9 Deazaguanine"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB06235",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Vadimezan"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Propentofylline"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The metabolism of Doxofylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The metabolism of Ramosetron can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The metabolism of 6 O benzylguanine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The metabolism of Binimetinib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The metabolism of Lisofylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The metabolism of Lobucavir can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The metabolism of Cafedrine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The metabolism of Theodrenaline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The metabolism of Bamifylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The metabolism of Proxyphylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The metabolism of Acefylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The metabolism of Etamiphylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The metabolism of Pentifylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The metabolism of Bufylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The metabolism of Bromotheophylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The metabolism of 8 chlorotheophylline can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Bicifadine"
                    },
                    {
                        "drugbank-id": "DB05708",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with GTS 21"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB00299",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Penciclovir"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00170",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Menadione"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "The metabolism of Pomalidomide can be increased when combined with NN344"
                    },
                    {
                        "drugbank-id": "DB06732",
                        "description": "The metabolism of Pomalidomide can be increased when combined with beta Naphthoflavone"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "The metabolism of Insulin beef can be increased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Gatifloxacin"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The metabolism of Viloxazine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Conjugated estrogens"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tocainide"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Famotidine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Caffeine"
                    },
                    {
                        "drugbank-id": "DB00060",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Interferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Pefloxacin"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Methoxsalen"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Thiabendazole"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rosoxacin"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Estrone sulfate"
                    },
                    {
                        "drugbank-id": "DB05396",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Albinterferon Alfa 2B"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06803",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Niclosamide"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Enrofloxacin"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB15119",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ropeginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB15131",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Interferon alfa 2c"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Imipramine can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Tizanidine"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Axitinib"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Theophylline"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Aminophylline"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Lepirudin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Bivalirudin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Alteplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding can be increased when Urokinase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Reteplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Anistreplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Tenecteplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Streptokinase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Dicoumarol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Ardeparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Phenindione is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Heparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Enoxaparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Coumarin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Ximelagatran is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Desmoteplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Ancrod is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Fibrinolysin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Sulodexide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Semuloparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Idraparinux is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Astaxanthin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Otamixaban is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Amediplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Danaparoid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Dalteparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Tinzaparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Ferulic acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Nadroparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Ditazole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Sodium citrate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Bemiparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Parnaparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Desirudin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Zinc citrate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Protein C is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Letaxaban is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Darexaban is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Monteplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Gabexate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Brinase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Tioclomarol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Melagatran is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Saruplase is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Dabigatran is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Argatroban is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Phenprocoumon is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when 4 hydroxycoumarin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Fluindione is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Clorindione is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Diphenadione is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when S Warfarin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Dipyridamole is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Troxerutin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Edetic acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Reviparin is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Pomalidomide can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of myelosuppression can be increased when Pomalidomide is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The serum concentration of Abemaciclib can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Belantamab mafodotin"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Silodosin"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Odanacatib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Dasabuvir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Ombitasvir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Talinolol can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Ertugliflozin can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Revefenacin can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Tezacaftor can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The serum concentration of Eliglustat can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Paritaprevir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Pomalidomide may increase the immunosuppressive activities of Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The risk or severity of adverse effects can be increased when Allopurinol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Pomalidomide is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The serum concentration of Lefamulin can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Pomalidomide is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dronedarone can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Lasmiditan can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Voxelotor"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of CNS depression can be increased when Tramadol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ziprasidone is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Darunavir"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Lopinavir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Haloperidol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Pomalidomide may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Pomalidomide is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Octreotide"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Pomalidomide is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Pomalidomide can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB14845",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Filgotinib"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Berotralstat"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}